Filing Flows › Xeris Biopharma Holdings (XERS) › Who owns the stock
Who owns Xeris Biopharma Holdings (XERS) stock
229 funds reported Xeris Biopharma Holdings (XERS) shares in their latest 13F filings, worth $934M in all. The largest holder is BlackRock ($115M). Last quarter 123 funds added to their stakes and 92 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 14,525,539 | $115M | increase | 2026-06-30 |
| Vanguard Group | 11,186,677 | $87.8M | increase | 2025-12-31 |
| D. E. Shaw | 7,804,758 | $61.8M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 7,340,229 | $58.1M | increase | 2026-06-30 |
| State Street | 4,821,566 | $38.2M | increase | 2026-06-30 |
| Geode Capital Management, LLC | 4,718,183 | $37.4M | increase | 2026-06-30 |
| Nuveen, LLC | 4,385,141 | $34.7M | increase | 2026-06-30 |
| Rosalind Advisors | 2,908,981 | $23.0M | decrease | 2026-06-30 |
| Qube Research & Technologies | 2,893,749 | $22.9M | decrease | 2026-06-30 |
| Vanguard Portfolio Management LLC | 2,626,208 | $20.8M | decrease | 2026-06-30 |
| Wellington Management Group LLP | 2,365,103 | $18.7M | increase | 2026-06-30 |
| Morgan Stanley | 2,337,096 | $18.5M | decrease | 2026-06-30 |
| Legal & General Group | 2,012,792 | $15.9M | increase | 2026-06-30 |
| Armistice Capital, LLC | 1,958,702 | $15.5M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 1,885,503 | $14.9M | decrease | 2026-06-30 |
Xeris Biopharma Holdings' latest quarter
Xeris Biopharma Holdings, Q3 2026: revenue $107M (+44% year over year), operating margin 15.8%, net earnings $11.3M, operating cash flow $35.5M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most XERS stock?
By the latest 13F filings: BlackRock ($115M); Vanguard Group ($87.8M); D. E. Shaw ($61.8M); Vanguard Capital Management LLC ($58.1M); State Street ($38.2M).
What is the short interest in XERS?
8,027,654 shares were sold short at the 2026-10-15 settlement, 11.46% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.